We do respect that a large variety of genetic and molecular variations have been identified in pancreatic cancer (i.e., K-ras, p16, p53, BRCA2, smad4 genes) in the past.38 However, translation of this scientific knowledge into clinical treatment regimen is still largely unrealized. The gene discussed is TP53; the disease is pancreatic neoplasm.